MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-16-2026
Atara Biotherapeutics Historical Prices 2011-2026 | ATRA
Annual Historical Prices Atara Biotherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.87 | 6.81 | 0.69 | 5.09 | 15.8 | 19.6 | 16.5 | 34.7 | 18.1 | 14.2 | 26.4 | 26.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.7 | 0.69 | 15.9 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Burford Capital Limited
BUR
|
10.6 | $ 4.72 | 0.11 % | $ 756 M |  Britain |
 |
Cabaletta Bio
CABA
|
2.82 | $ 3.35 | 2.76 % | $ 337 M |  USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 3.03 | -0.66 % | $ 4.99 M |  Israel |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
311 | $ 333.44 | -1.76 % | $ 43.7 B | USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.69 | 1.93 % | $ 8.88 B |  Australia |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Aligos Therapeutics
ALGS
|
6.67 | $ 7.81 | -10.64 % | $ 77.2 M | USA |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Esperion Therapeutics
ESPR
|
2.7 | $ 2.16 | 5.37 % | $ 449 M | USA |
 |
Evogene Ltd.
EVGN
|
0.81 | $ 0.82 | -0.12 % | $ 27.9 M | Israel |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
|
Forte Biosciences
FBRX
|
25.9 | $ 32.09 | -1.02 % | $ 416 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
26.7 | $ 21.24 | -0.65 % | $ 993 M | USA |
 |
Galapagos NV
GLPG
|
28.9 | $ 29.07 | 0.66 % | $ 2.69 B |  Belgium |
 |
Genmab A/S
GMAB
|
33.5 | $ 29.04 | -0.07 % | $ 18.6 B |  Danmark |
 |
GT Biopharma
GTBP
|
0.47 | $ 0.38 | -2.88 % | $ 2.1 M | USA |
 |
BioNTech SE
BNTX
|
91.2 | $ 99.63 | 1.24 % | $ 27.2 B | Germany |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Hoth Therapeutics
HOTH
|
0.81 | $ 0.71 | 9.78 % | $ 9.8 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M |  Canada |
 |
Harmony Biosciences Holdings
HRMY
|
28 | $ 29.5 | 0.72 % | $ 1.7 B | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.3 | $ 1.55 | -0.96 % | $ 399 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
4.37 | $ 4.16 | 0.12 % | $ 445 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 24.32 | -3.07 % | $ 3.09 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | USA |
 |
ImmuCell Corporation
ICCC
|
6.43 | $ 7.61 | -1.55 % | $ 68.7 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.48 | -0.34 % | $ 394 M | Britain |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
|
Immatics N.V.
IMTX
|
8 | $ 10.88 | -0.68 % | $ 684 M | Germany |
 |
Incyte Corporation
INCY
|
99.7 | $ 97.67 | -0.03 % | $ 19.1 B | USA |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |